Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine and danazol in ITP
NCT03909763Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 2 trial of berberine in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
berberine
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03909763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03909763.